Clinical Trials Logo

Asthma clinical trials

View clinical trials related to Asthma.

Filter by:

NCT ID: NCT04077528 Recruiting - Clinical trials for Adult Severe Asthma Patients Treated in France

Research on Severe Asthma

RAMSES
Start date: September 10, 2019
Phase:
Study type: Observational

The French Society for Respiratory diseases (SPLF), through its Asthma and Allergy working group (G2A), wishes to set up a national cohort of severe asthma patients to describe this population and the use of step 4 and 5 treatment. This study also meets the demand for post - registration studies required by the Health Authorities for biotherapies and bronchial thermoplasty. Other European or international cohorts of asthmatic patients exist and RAMSES could contribute to data sharing initiatives.

NCT ID: NCT04072562 Completed - Asthma Clinical Trials

A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.

Start date: September 19, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the relative bioavailability of the AZD7594 nebulized formulations (test) and the dry powder formulation (reference). The study results will provide information on the pharmacokinetic (PK) profile following use of the 2 devices to be used in further clinical development.

NCT ID: NCT04063631 Recruiting - Asthma Clinical Trials

Pulmonary Epithelium, Immunology and Development of Asthma: Breathing Together

Start date: February 20, 2017
Phase:
Study type: Observational

The investigators want to know why some babies wheeze and some of these go on to develop asthma. The investigators are going to find out if babies who develop wheeze and asthma have abnormal airway lining cells (taken from the nose) when they are born and what happens to these cells as they get older. The study will last three years. Parents will be asked to fill in a monthly health questionnaire. The tests on the babies are all in routine clinical use: a urine sample, a blood test from a heel or finger prick, swabs from the nose and throat to look at the microbiome, and a brushing of cells from the inside of the nose. These tests will be performed at 5-10 days old, and at one and three years. Parents will be asked to fill in online monthly health questionnaire. Some babies will have the swabs repeated at 3 and 6 months, and those who wheeze in the first 3 years of life, samples during the illness and after recovery.

NCT ID: NCT04061291 Completed - Asthma Clinical Trials

Study to Explore the Relationship Between the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device Against Existing Measures of Lung Disease

EXHALE 1A
Start date: February 3, 2018
Phase:
Study type: Observational

A cross-sectional, observational study of EBC H2O2 levels, as measured by a novel device, 'Inflammacheck™', and other markers of disease severity and symptom control in patients with Asthma and COPD and volunteers with no history of lung disease.

NCT ID: NCT04060823 Completed - Asthma Clinical Trials

Implementing a Healthcare Provider Education Intervention in Rural Communities to Reduce Asthma Morbidity

Start date: August 12, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to pilot test the implementation of healthcare provider education interventions to improve asthma outcomes in rural youth residing in Bradford County, Florida. The investigators propose to assess the feasibility and acceptability of implementing the Easy Breathing program a rural, medically underserved county and evaluate changes in healthcare provider practices and asthma-related outcomes of rural youth diagnosed with asthma.

NCT ID: NCT04057521 Completed - Asthma Clinical Trials

Coordinated HEalthcare for Complex Kids

CHECK
Start date: April 1, 2016
Phase: N/A
Study type: Interventional

The University of Illinois Health and Health Sciences System (UI Health) developed an integrated care management quality improvement model designed to provide comprehensive care coordination for Medicaid insured minority children and young adults with chronic health conditions living in Chicago. This program, called CHECK (Coordinated HEalthcare for Complex Kids), targeted children and young adults with chronic disease.

NCT ID: NCT04056364 Not yet recruiting - COPD, Asthma,ACO Clinical Trials

Diagnostic Value of Sputum Cytology in Asthma-COPD Overlap

Start date: September 2019
Phase:
Study type: Observational

The aim of this study is to evaluate the diagnostic value of sputum cell counts in differentiation between asthma, COPD and ACO. to examine the relationship between sputum cell counts in bronchial revers¬ibility and bronchial hyperresponsiveness

NCT ID: NCT04051710 Completed - Bronchial Asthma Clinical Trials

Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

QVR
Start date: March 12, 2019
Phase: Phase 3
Study type: Interventional

To compare the therapeutic equivalence of Beclomethasone Dipropionate MDI (Inhalation Aerosol) 0.04 mg/ INH with the marketed QVAR® 40 mcg (Beclomethasone dipropionate hydrofluoroalkane (HFA)) and to demonstrate superiority of both active treatments over placebo.

NCT ID: NCT04051060 Enrolling by invitation - Asthma Clinical Trials

Evaluation of Exercise Capacity and Activity Role Adequacy in Patients With Adult Bronchial Asthma

ASTHMA
Start date: February 1, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of this study was to evaluate exercise capacity and activity role adequacy in patients with adult bronchial asthma.

NCT ID: NCT04049175 Terminated - Clinical trials for Asthma; Eosinophilic

Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma

PERSEA
Start date: August 28, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this phase III Study is to demonstrate the efficacy of at least one dose of CHF 6532 on moderate and severe asthma exacerbations rate compared to placebo.